0R3M
Sign in
Vivoryon Therapeutics N.V.
Save
52.52M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Vivoryon Therapeutics N. V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta.
Similar securities
Based on sector and market capitalization
Report issue